Profile
AVDL ZTS HLN TAK TEVA ITCI
Company Name Avadel Pharmaceuticals plc Zoetis Inc. Haleon plc Takeda Pharmaceutical Company Limited Teva Pharmaceutical Industries Limited Intra-Cellular Therapies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $907.35M $70.23B $48.53B $47.75B $20.71B $14.05B
Employees 0.19K 13.80K 24.56K 49.28K 33.89K 0.86K
CEO Mr. Gregory J. Divis Jr. Ms. Kristin C. Peck Mr. Brian James McNamara Mr. Christophe Weber Mr. Richard D. Francis Dr. Sharon Mates Ph.D.
Ratings
Trading
AVDL ZTS HLN TAK TEVA ITCI
Last Close $9.39 $161.69 $10.57 $14.27 $18.07 $131.87
High 52 $16.91 $196.48 $10.77 $15.37 $22.77 $131.91
Low 52 $6.59 $144.45 $8.24 $12.6 $12.82 $64.96
Price vs. 52 Week High -44.47 % -17.71 % -1.86 % -7.16 % -20.64 % -0.03 %
Price vs. 52 Week Low 42.49 % 11.93 % 28.28 % 13.25 % 40.95 % 103 %
Total Return
AVDL ZTS HLN TAK TEVA ITCI
1 Month Return 29.34 % 5.25 % 9.48 % -0.55 % 27.61 % 0 %
3 Month Return 15.78 % -5.68 % 10.68 % 5.47 % 7.24 % 3.83 %
6 Month Return -41.09 % -8.56 % 9.99 % 3.56 % 5.61 % 44.45 %
9 Month Return -39.46 % -12.72 % 7.75 % 2.88 % 3.67 % 79.15 %
YTD Return -10.66 % -0.76 % 10.8 % 7.78 % -18.01 % 57.89 %
1 Year Return -40.68 % -3.83 % 27.97 % 6.73 % 12.94 % 101.14 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AVDL ZTS HLN TAK TEVA ITCI
Dividend Yield Percentage (TTM) - 1.18 % 0.02 % 4.58 % - -
Dividend Paid and Capex Coverage Ration (TTM) -15336544.2 % 2.05 % - 1.76 % 2.5 % -227.26 %
Dividend Per Share (TTM) - 1.86 % 0.07 % 196 % - -
Payout Ratio (TTM) - 31.62 % - 145.09 % - -
Growth
AVDL ZTS HLN TAK TEVA ITCI
Asset Growth -0.28 % 8.25 % -9.55 % 87.69 %
Gross Profit Growth 467.32 % 1.76 % 5.47 % 44.88 %
Revenue Growth 504.79 % 5.87 % 4.4 % 46.62 %
Revenue 3 Year - 33.13 % 1.52 % 556.51 %
Revenue 5 Year 12.28 % 103.83 % -5.5 % 600974.32 %
Revenue 10 Year 335.68 % 152.69 % -38.45 % 32663.23 %
EBIT Growth 74.65 % -64.98 % -169.63 % 26.77 %
Net Income Growth 69.53 % -54.56 % -193.2 % 46.54 %
Net Income 3 Yeari Growth Per Share 61.15 % -61.74 % -482.97 % 79.29 %
Net Income 5 Yeari Growth Per Share 42.22 % 32.36 % -58.26 % 72.95 %
Net Income 10 Yeari Growth Per Share 78.11 % 35.42 % -140.46 % 32.41 %
Operating Income Growth 69.24 % -56.36 % -169.98 % 26.77 %
Operating Cash Flow Growth (CFG) 63.5 % -26.69 % -8.85 % 41.08 %
Operating 3 Year CFG 62.67 % -29.25 % 52.26 % 77.79 %
Operating 5 Year CFG 51.88 % 118.64 % 123.59 % 69.4 %
Operating 10 Year CFG -68.15 % 384.17 % -81.66 % 10.87 %
EPS Growth 74.5 % -54.92 % -190 % 50.68 %
EPS Diluted Growth 74.5 % -54.86 % -190 % 50.68 %
Book Value Per Share -29.07 % 13.54 % -30.36 % 80.54 %
Share Holder 3 Year Equity Growth Per Share -41.93 % 40.38 % -49 % 116.52 %
Share Holder 5 Year Equity Growth Per Share 199.43 % 41.33 % -62.86 % 215.14 %
Share Holder 10 Year Equity Growth Per Share 12.91 % 195.14 % -82.6 % 164.65 %
Dividend Per Share Growth - 1.95 % - -
Dividend 3 Year Growth Per Share - 1.19 % - -
Dividend 5 Year Growth Per Share - 101.42 % -100 % -
Dividend 10 Year Growth Per Share - 102.58 % -100 % -
Debt Growth -95.18 % 10.53 % -10.29 % 0.25 %
Free Cash Flow Growth 63.5 % -31.4 % -11.05 % 40.95 %
Updated On 31 Dec 2024 31 Mar 2024 31 Dec 2024 31 Dec 2024
Profitability
AVDL ZTS HLN TAK TEVA ITCI
Gross Profit Margin TTM 90.97 % 69.85 % 61.52 % 54.74 % 48.74 % 91.63 %
Return on Assets TTM -29.73 % 17.46 % 4.2 % 1.38 % -4.17 % -5.46 %
Return on Equity TTM -65.73 % 49.65 % 8.73 % 2.83 % -26.15 % -7.4 %
Return on Capital Employed TTM -36.74 % 31.33 % 7.74 % 3.62 % -1.14 % -10.05 %
Net Income Per EBT TTM 99.49 % 79.35 % 75.5 % 89.75 % 127.75 % 100.64 %
EBT Per Ebit TTM 115.75 % 92.36 % 86.58 % 49.18 % 423.43 % 63.57 %
EBIT Per Revenue TTM -25.07 % 36.65 % 19.64 % 10.3 % -1.83 % -17.15 %
Cash Flow To Debt Ratio TTM -2741.53 % 43.79 % - 22.2 % 6.9 % -430.93 %
Receivables Turnover TTM 4.96 7.03 5.9 6.23 5.41 4.09
Payables Turnover TTM 2.08 6.45 2.19 4.5 3.85 2.18
Inventory Turnover TTM 0.75 1.21 3.63 1.66 2.82 2.17
Fixed Asset Turnover TTM 7847.66 % 256.4 % 584.75 % 226.93 % 334.34 % 4569.25 %
Asset Turnover TTM 102.97 % 65.01 % 32.73 % 30.31 % 42.07 % 49.79 %
Operating Cash Flow Per Share TTM -0.48 6.55 - 677.91 1.1 -0.71
Free Cash Flow Per Share TTM -0.49 5.1 - 483.45 0.66 -0.71
Cash Per Share TTM 76.54 % 440.62 % 24.05 % 33229.49 % 291.26 % 970.67 %
Operating Cash Flow Sales Ratio TTM -27.62 % 31.9 % - 23.47 % 7.54 % -10.75 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.41 % 77.82 % - 71.32 % 60.06 % 100.44 %
Cash Flow Coverage Ratios TTM -2741.53 % 43.79 % - 22.2 % 6.9 % -430.93 %
Price To Free Cash Flows Ratio TTM -19.34 30.56 - 8.85 27.87 -191.12
Price To Operating Cash Flows Ratio TTM -19.38 24.02 - 6.31 16.55 -185.85
Price Cash Flow Ratio TTM -19.38 24.02 - 6.31 16.55 -185.85
Income Statement (TTM)
AVDL ZTS HLN TAK TEVA ITCI
Revenue $0.17B $9.26B $11.23B $4263.76B $16.54B $0.68B
Gross Profit $0.15B $6.54B $6.95B $2832.26B $8.06B $0.62B
Gross Profit Ratio 90.97% 70.62% 61.85% 66.43% 48.74% 91.63%
EBITDA $-0.04B $3.87B $2.51B $874.6B $0.72B $-0.12B
Net Income $-0.05B $2.49B $1.44B $144.07B $-1.64B $-0.07B
EPS Diluted -0.51 5.47 0.32 45.58 -1.45 -0.72
Balance Sheet (MRQ)
AVDL ZTS HLN TAK TEVA ITCI
Long Term Debt $0B $5.39B $8.54B $5029.93B $16B $0.01B
Total Liabilities $0.09B $9.47B $18.09B $7834.79B $33.61B $0.22B
Total Equity $0.07B $4.77B $16.22B $7274.01B $5.73B $1.15B
Total Investments $0.02B $0B $0.08B $445.7B $0B $0.69B
Total Debt $0B $6.74B $10.1B $4843.75B $18.08B $0.02B
Total Assets $0.16B $14.24B $34.32B $15108.79B $39.33B $1.37B
Cash Flow Statement (TTM)
AVDL ZTS HLN TAK TEVA ITCI
Net Income $-0.05B $2.5B $1.44B $144.07B $-1.96B $-0.07B
Inventory $-0.01B $-0.04B $0.22B $-115.74B $0.17B $-0.01B
Dividends Paid $0B $-0.79B $-0.57B $-287.19B $0B $0B
Operating Cash Flow $-0.05B $2.95B $2.3B $716.34B $1.25B $-0.07B
Capital Expenditure $0B $-0.66B $-0.25B $-480.73B $-0.5B $-0B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 4.86
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 1.17
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 9.69
ALVOW Alvotech 1.79
AMPH Amphastar Pharmaceuticals, Inc. 24.11
AMRX Amneal Pharmaceuticals, Inc. 7.42
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 66.29
APUS Apimeds Pharmaceuticals US, Inc 0.00001
AQST Aquestive Therapeutics, Inc. 2.79
ASRT Assertio Holdings, Inc. 0.6101
ATNX Athenex, Inc. 0.2031
AYTU Aytu BioPharma, Inc. 1.25
ETFs With Exposure to AVDL
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.03396 200.84
VTI Vanguard Total Stock Market Index Fund 0 277.95
IWV iShares Russell 3000 ETF 0.00146 321.38
IWO iShares Russell 2000 Growth ETF 0.06607 261.53
VHT Vanguard Health Care Index Fund 0.01 242.71
GWX SPDR S&P International Small Cap ETF 0.049644 34.31
BIB ProShares Ultra Nasdaq Biotechnology 0.0270575 39.68
HDG ProShares Hedge Replication ETF 0.00410581 48.808
UWM ProShares Ultra Russell2000 0.0106151 32.9
VTHR Vanguard Russell 3000 Index Fund 0 249.52
ONEQ Fidelity Nasdaq Composite Index ETF 0.01 70.57
FHLC Fidelity MSCI Health Care Index ETF 0.0155639 62.53
TILT FlexShares Morningstar US Market Factors Tilt Index Fund 0.0036 206.64
URTY ProShares UltraPro Russell2000 0.0061247 32.45
AADR AdvisorShares Dorsey Wright ADR ETF 1.56 75.18
FAD First Trust Multi Cap Growth AlphaDEX Fund 0.02 134.02
FYC First Trust Small Cap Growth AlphaDEX Fund 0.1 72.105
FYX First Trust Small Cap Core AlphaDEX Fund 0.05 90.665
GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF 0 63.95
ISCB iShares Morningstar Small-Cap ETF 0.01775 54.68
ISCG iShares Morningstar Small-Cap Growth ETF 0.03695 46.07
SMMV iShares MSCI USA Small-Cap Min Vol Factor ETF 0.05715 41.485
VFMO Vanguard U.S. Momentum Factor ETF 0.06 157.16
VTWG Vanguard Russell 2000 Growth Index Fund 0.06 191.1
VTWO Vanguard Russell 2000 Index Fund 0.03 81.16
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 94.59
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 94.58
VQNPX Vanguard Growth and Income Fund 0 60.39
VGIAX Vanguard Quantitative Funds - Vanguard Growth and Income Fund 0 98.57
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 47.01
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 47
VBINX Vanguard Balanced Index Fund Investor Shares 0 47
ESML iShares ESG Aware MSCI USA Small-Cap ETF 0.05904 38.76
IBBQ Invesco Nasdaq Biotechnology ETF 0.094 19.495
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.12198 5.111
VTSAX Vanguard Total Stock Market Index Fund 0 135.4
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.09391 5.75
WSML.L iShares MSCI World Small Cap UCITS ETF 0.0093 7.5205
VITSX Vanguard Total Stock Market Index Fund 0 135.42
EWSA.AS iShares MSCI World Small Cap ESG Enhanced UCITS ETF 0.02052 5.0968
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.09391 5.743
QQQS Invesco NASDAQ Future Gen 200 ETF 0.662 23.64
IBRN iShares Neuroscience and Healthcare ETF 1.87272 21.56
IUSN.DE iShares MSCI World Small Cap UCITS ETF 0.01237 6.681
CUSS.L iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced UCITS ETF USD (Acc) 0.03702 493.9
BBSC JPMorgan BetaBuilders U.S. Small Cap Equity ETF 0.06 61.105
VHCIX Vanguard HealthCare Index Fund Admiral Shs 0.01 122.77
ILDR First Trust Innovation Leaders ETF 0.2 24.8106
VMNFX Vanguard Market Neutral Fund -34.38 13.44
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 254.04
RSSL Global X Funds 0.03 78.89
WSML iShares MSCI World Small-Cap ETF 0.01135 25.8707
Unlock